GERS (GERS) Stock Price & Analysis
GERS (GERS) rose 0.00% to USD 0 as of June 10, 2026 at 07:55 UTC, according to Nexqual real-time market data.
GERS last closed at USD 0; the session ranged USD 0.04–0.04 on volume of 10,000 shares. Market capitalization is $2,006, with a 52-week range of USD 0–0.13 (PNK). Source: Nexqual, June 10, 2026 at 07:55 UTC.
Key Statistics (as of June 10, 2026 at 07:55 UTC)
| Price | USD 0 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 0 |
| Open | USD 0.04 |
| Day Range | USD 0.04 – 0.04 |
| 52-Week Range | USD 0 – 0.13 |
| Volume | 10,000 shares |
| Market Cap | $2,006 |
| Exchange | PNK |
Technical Analysis (GERS)
Nexqual's technical model rates GERS "STRONG SELL" based on 0 bullish and 5 bearish signals across 124 daily candles, as of June 10, 2026 at 07:55 UTC.
| Overall Signal | STRONG SELL |
|---|---|
| RSI (14) | 100 (overbought) |
| vs SMA50 | Below (USD 0) |
| MACD | 0 (negative) |
Analyst Ratings (GERS)
Wall Street analysts rate GERS "None", per Nexqual as of June 10, 2026 at 07:55 UTC.
| Consensus Rating | None |
|---|
Earnings (GERS)
Source: Nexqual, June 10, 2026 at 07:55 UTC.
Financials & Fundamentals (GERS)
| Total Revenue | $308,098 |
|---|---|
| Revenue Growth (YoY) | +57.60% |
| Gross Margin | +100.00% |
| Operating Margin | -101.19% |
| Profit Margin | -186.67% |
| Current Ratio | 0.01 |
| Total Cash | $18,394 |
| Total Debt | $5.83M |
Source: Nexqual, June 10, 2026 at 07:55 UTC.
Financial Health Score (GERS)
Nexqual rates GERS's overall financial health "Mixed" across five dimensions, as of June 10, 2026 at 07:55 UTC.
| Growth | Strong — Revenue +58% YoY (latest Q) |
|---|---|
| Profitability | Critical — Heavily loss-making — early-stage company |
| Balance Sheet | Mixed — $18K cash vs $6M debt |
| Cash Flow | Solid — Operating cash flow $6K |
| Efficiency | Mixed — No data |
Ownership (GERS)
| Insider Ownership | +0.67% |
|---|---|
| Institutional Ownership | +0.00% |
| Shares Outstanding | 20.06M |
Source: Nexqual, June 10, 2026 at 07:55 UTC.
Leadership (GERS)
GERS is led by John W. Davis, Vice President of Operations, per Nexqual as of June 10, 2026 at 07:55 UTC.
| Vice President of Operations | John W. Davis |
|---|
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| PSUD | PetroSun, Inc. | USD 0.02 | ▼ 10.53% |
| GSPI | Green Star Products, Inc. | USD 0 | ▼ 23.53% |
| HESG | HEALTH SCIENCES GROUP INC | USD 0 | ▲ 0% |
| NNFC | NANOFORCE INC | USD 0 | ▲ 0% |
| DEWM | DEWMAR INTL BMC INC | USD 0 | ▲ 0% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 07:55 UTC. This page is informational and not investment advice.